India to Dominican Republic: Budesonide Export Trade Route

The India to Dominican Republic Budesonide corridor is one of India's established pharmaceutical export routes, with 24 shipments documented worth a combined $1.2M USD. The route is dominated by MEDISPRAY LABORATORIES PRIVATE LIMITED, which alone accounts for roughly 50% of all export value, reflecting the consolidated nature of India's budesonide manufacturing sector.

Across 7 active suppliers, the average shipment value stands at $49.8K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 72% of all shipments, consistent with budesonide's non-urgent bulk-order profile.

Shipment activity peaks during January–March, with an average transit time of 21 days port-to-port. The route has recorded an annual growth rate of 10.2%, placing it at rank #13 among India's top budesonide export destinations globally.

On the import side, key buyers of Indian budesonide in Dominican Republic include GENERICAL S.A, GENERICAL S, PHARMACEUTICAL TECHNOLOGY and 5 others. GENERICAL S.A is the single largest importer with 8 shipments valued at $600.7K USD.

India's budesonide exports to Dominican Republic are driven primarily by a handful of large-scale manufacturers. MEDISPRAY LABORATORIES PRIVATE LIMITED with 8 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 7 active exporters signals a competitive but concentrated market — buyers in Dominican Republic benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — MEDISPRAY LABORATORIES PRIVATE LIMITED, MEDISPRAY LABORATORIES PVT LTD, CIPLA LIMITED — together account for 88% of total trade value on this route. The average shipment value of $49.8K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as airplus venticaps(twin pck)formoterol fumarate 6mcg+budesonide 200mcg rotacaps)(19392packx1x60's=1163520 nos)(twin pack) and airplus venticaps(twin pck)formoterol fumarate 6mcg+budesonide 200mcg rotacaps)(19274packx1x60's=1156440 nos)(twin pack), suggesting that buyers in Dominican Republic tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, GENERICAL S.A is the largest importer with 8 shipments worth $600.7K USD — representing 50% of all budesonide imports from India on this route. A total of 8 buyers are active on this corridor.